Molecule shows effectiveness against drug-resistant myeloma

BOSTON––A molecule that targets the cell’s machinery for breaking down unneeded proteins can kill multiple myeloma cancer cells resistant to the frontline drug Velcade, researchers at Dana-Farber Cancer Institute have found.

JUMP